Strategic realignment and innovation: Investing in China toward 2030

China is back on the radar for global investors, but for very different reasons than a decade ago.

As the world contends with a new era of geopolitical recalibration and economic divergence, China’s evolving strategic posture presents both an opportunity and a challenge for institutional investors. The recent white paper “China: Strategic Choices in a Changing Century” authored by Aidan Yao, Claire Huang, and Alessia Berardi of the Amundi Investment Institute offers a meticulous exploration of China’s latest Five-Year Plan and its implications for asset allocation. This paper, while ostensibly macroeconomic in tone, is crucial reading for superannuation funds, endowments, not-for-profits and family offices seeking to engage with China through long-term, resilient investment strategies.

The authors begin by contextualising China’s policy trajectory within a framework of intensifying geopolitical tensions, particularly with the United States. Since President Xi Jinping’s 2017 proclamation that the world was undergoing “momentous changes unseen in a century,” China has moved from passive integration with global markets to a more assertive, sometimes defensive posture. The draft 15th Five-Year Plan (FYP) is not merely a roadmap for development, but a crystallisation of this strategic shift towards national resilience.

At the core of this plan lies a deliberate pivot from growth maximisation to resilience building. For institutional investors, particularly those with multi-decade horizons, this has significant implications. The elevation of supply chain autonomy and technological self-reliance signals a rebalancing away from cyclical growth sectors towards industries aligned with state priorities. Investment opportunities in semiconductors, green energy, artificial intelligence and advanced manufacturing will be disproportionately favoured by state support.

A central message from Yao, Huang and Berardi is that China’s macro policy apparatus is being reconfigured around geopolitical reality. Traditional levers such as interest rate manipulation and fiscal stimulus are now constrained by the overarching goal of strategic autonomy. The People’s Bank of China, for example, has resisted wholesale easing, opting instead for a “just enough” stimulus stance aimed at maintaining stability without compromising broader goals. This constraint-based policy framework may temper the appeal of Chinese sovereign debt in the short term, but it also points to a more disciplined, less bubble-prone macroeconomic environment, potentially favourable for long-term capital.

From an asset allocation perspective, Amundi’s assessment reinforces a bifurcated view of the Chinese market. On one hand, the innovation-driven “new China” is gaining investor favour. Sectors such as biotech, robotics and smart infrastructure have benefitted from targeted industrial policy and stand to outperform if the FYP is executed effectively. On the other hand, “old China”, comprising real estate, traditional manufacturing and energy-intensive industries, remains mired in regulatory uncertainty and structural overhangs. This polarity invites a barbell approach for institutional allocators, combining growth-oriented thematic equities with defensive positions in select state-backed bonds.

For super funds and endowments, whose mandates allow for allocation across geographies and sectors, China’s path offers a unique alignment with the concept of “patient capital.” The emphasis on industrial resilience and consumption upgrading may not yield immediate outperformance, but over a five-to-ten-year horizon, these policy tailwinds could underpin stable earnings and progressive liberalisation. The pledge to increase household consumption as a share of GDP, for instance, aligns with longstanding global investor hopes for a rebalanced Chinese growth model.

An important tactical consideration highlighted in the report is the relative currency outlook. Amundi’s strategists forecast room for appreciation in the renminbi, citing not only potential US dollar weakness but also China’s robust trade surplus and external balance. Currency exposure, often a source of trepidation for institutional investors allocating to emerging markets, may instead be a performance driver under current conditions.

Crucially, the US–China relationship is not being reset, but rather recalibrated. The temporary trade truce signed in late 2025 underscores a pragmatic coexistence between the two powers, but not détente. While some tariffs have been reduced and export restrictions eased, both nations remain committed to technological and strategic decoupling. This continued rivalry will anchor China’s inward turn and could act as a long-term catalyst for onshore innovation and capital deepening.

Given this complexity, the role of macro research such as that undertaken by Yao, Huang and Berardi is vital. Their analysis not only decodes the logic behind China’s FYP, but also translates it into a practical lexicon for institutional investors: anticipate volatility, embrace policy-linked sectors, and align with strategic state intent. For family offices, this may mean direct investments or co-investments in Chinese venture and growth funds aligned with innovation goals. For super funds, a strategic tilt in EM allocations towards China’s innovation complex may be warranted.

The muted short-term market reaction to the Plenum’s announcements, as the authors rightly observe, reflects investor demand for execution, not vision. Markets are awaiting concrete policy follow-through at the National People’s Congress in March 2026. Until then, institutional capital will likely remain circumspect, favouring quality Chinese names already benefiting from policy tailwinds rather than making broad-based bets.

Finally, this white paper reframes China not as a tactical trade, but as a structural allocation question. For investment committees deliberating over EM exposure, the decision is no longer simply about GDP growth or valuation metrics, but about alignment with an evolving economic doctrine rooted in resilience, autonomy and selective openness. The fact that “opening up” has been promoted to the fifth-highest policy priority in the FYP signals not retreat, but recalibrated engagement, a message that long-horizon investors must heed.

For institutional investors, the insights provided by Aidan Yao, Claire Huang and Alessia Berardi are more than a snapshot of policy evolution; they are a strategic briefing for investing with capital at scale. Their work challenges asset owners to transcend dated narratives about China and embrace a framework grounded in national ambition, sectoral transformation and cautious coexistence with the West. For those prepared to walk the long road, the prize may well be access to the most consequential industrial transformation of the 21st century.

Nicholas Way

Nicholas Way is a contributing editor at The Inside Adviser and has covered business, retirement, politics, human resources and personal investment over a 50-year career.